These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Computer graphic modeling in drug design--conformational analysis of antifolate binding to avian dihydrofolate reductase: crystal and molecular structures of 2,4-diamino-5-cyclohexyl-6-methylpyrimidine and 5-cyclohexyl-6-methyluracil. Cody V, Ciszak E. Anticancer Drug Des; 1991 May; 6(2):83-93. PubMed ID: 2039584 [Abstract] [Full Text] [Related]
4. Crystallographic studies of the antineoplastic antifolate 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) ethanesulfonate salt. Cody V. Cancer Biochem Biophys; 1983 May; 6(3):173-7. PubMed ID: 6850552 [Abstract] [Full Text] [Related]
6. CNDO/2 molecular orbital calculations on the antifolate DAMP and some related species: structural geometries, ring distortions, change distributions and conformational characteristics. Welsh WJ, Cody V, Mark JE, Zakrzewski SF. Cancer Biochem Biophys; 1983 Dec; 7(1):27-38. PubMed ID: 6667452 [Abstract] [Full Text] [Related]
7. Inhibition of human dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. A quantitative structure-activity relationship analysis. Hathaway BA, Guo ZR, Hansch C, Delcamp TJ, Susten SS, Freisheim JH. J Med Chem; 1984 Feb; 27(2):144-9. PubMed ID: 6694162 [Abstract] [Full Text] [Related]
9. A comparison of the inhibition of bovine and murine leukemia dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-X-phenyl)-s-triazines. Guo ZR, Dietrich SW, Hansch C, Dolnick BJ, Bertino JR. Mol Pharmacol; 1981 Nov; 20(3):649-56. PubMed ID: 7329407 [No Abstract] [Full Text] [Related]
13. Inhibition of dihydrofolate reductase. 3. 4.6-Diamino-1,2-dihydro-2,2-dimethyl-1-(2-substituted-phenyl)-s-triazine inhibition of bovine liver and mouse tumor enzymes. Kim KH, Dietrich SW, Hansch C, Dolnick BJ, Bertino JR. J Med Chem; 1980 Nov; 23(11):1248-51. PubMed ID: 7452676 [Abstract] [Full Text] [Related]
14. Ab initio studies of 2,4-diamino triazine and its complexes with ligands: a model for inhibitor-active site interactions of dihydrofolate reductase. Sapse AM, Waltham MC, Bertino JR. Cancer Invest; 1994 Nov; 12(5):469-76. PubMed ID: 7922702 [Abstract] [Full Text] [Related]
15. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase. Jones TR, Varney MD, Webber SE, Lewis KK, Marzoni GP, Palmer CL, Kathardekar V, Welsh KM, Webber S, Matthews DA, Appelt K, Smith WW, Janson CA, Villafranca JE, Bacquet RJ, Howland EF, Booth CL, Herrmann SM, Ward RW, White J, Moomaw EW, Bartlett CA, Morse CA. J Med Chem; 1996 Feb 16; 39(4):904-17. PubMed ID: 8632414 [Abstract] [Full Text] [Related]
16. Comparative structure-activity relationships of antifolate triazines inhibiting murine tumor cells sensitive and resistant to methotrexate. Selassie CD, Hansch C, Khwaja TA, Dias CB, Pentecost S. J Med Chem; 1984 Mar 16; 27(3):347-57. PubMed ID: 6699880 [Abstract] [Full Text] [Related]
17. 2,4-Diaminothieno[2,3-d]pyrimidine lipophilic antifolates as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase. Rosowsky A, Papoulis AT, Queener SF. J Med Chem; 1997 Oct 24; 40(22):3694-9. PubMed ID: 9357537 [Abstract] [Full Text] [Related]
18. Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. Hansch C, Hathaway BA, Guo ZR, Selassie CD, Dietrich SW, Blaney JM, Langridge R, Volz KW, Kaufman BT. J Med Chem; 1984 Feb 24; 27(2):129-43. PubMed ID: 6420569 [Abstract] [Full Text] [Related]